ArticleMolecular and cellular biochemistry2026

Arbutin as a promising cardioprotective anticancer adjuvant with doxorubicin in solid Ehrlich carcinoma through targeting NEK7-dependent inflammasome/SIRT1/caspase-3/oxidative stress pathways.

Eman R Abdelmonaem et al.PubMed ↗Publisher ↗

No numbers read from the abstract.